In today's episode we focus on the EY report on the Pharma supply chains of the future, and discuss the impact of global events and how a new supply chain model can emerge in the pharma industry.

The speakers discuss the future of pharmaceutical supply chains in the wake of the COVID-19 pandemic and other geopolitical events and shifts that are unfolding around us. The discussion covers the impact of global events that have led to a revaluation of globalized supply chain models and a creation of a new, optimised model where the end-to-end visibility is a crucial factor. Join us as we explore the future of pharmaceutical supply chains and their adaptability in the face of challenges.